Dr Mehta has extensive biotechnology and financial industry experience, and since 2006 has been managing director of Gemini Strategies, a manager of small-cap institutional funds with investments in the life science and medical device industry.
Dr Mehta was previously an investment banker at Granite Financial Group and a principal at TSG Partners, where he developed corporate strategies for life science, diagnostic, biotechnology and medical device companies.
Jim Joyce, chairman and CEO of Aethlon Medical, said: “Prashant’s unique spectrum of expertise allows him to confidently navigate the science, business and financial industry. His presence will further increase the opportunities we have to leverage our Hemopurifier platform technology to establish business relationships in the US and abroad.”